来自Bacillus subtilis的有希望的抗真菌脂:其特征和对作用模式的洞察力
Swetha Ramesh1, Utpal Roy2, Subhasish Roy3
1Department of Biological Sciences, BITS Pilani K.K. Birla Goa Campus, NH 17B Bypass Road, Sancoale, Goa, 403726, India.
Applied microbiology and biotechnology
|January 22, 2024
概括
这项研究确定了一种新型的抗真菌脂,AF3,来自细菌细菌,对Candida albicans具有强大的活性. AF3显示生物相容性和破坏真菌细胞膜,显示作为一种新的抗真菌药物候选人的承诺.
科学领域:
- 微生物学 微生物学
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 越来越多的抗真菌耐药性需要新的治疗药物.
- 脂是一种具有抗菌性能的有前途的自然化合物.
研究的目的:
- 描述从细菌细菌中分离出来的抗真菌脂AF3.
- 评估其作为潜在的抗真菌药物的疗效,作用机制和生物相容性.
主要方法:
- 循环二重化,FTIR和NMR光谱用于结构分析.
- 针对真菌菌株的最小抑制度 (MIC) 测定.
- 使用哺乳动物细胞进行生物相容性测试.
- 显微镜 (SEM,TEM,AFM) 和流细胞计测试以评估细胞损伤和膜完整性.
- 光探针 (AO/PI,FUN-1,DPH,di-8-ANEPPS,DCFH-DA) 用于研究膜透,脱极化和反应性氧物种 (ROS) 生产.
主要成果:
- AF3表现出强大的抗真菌活性,低MIC (4-8 mg/L) 对测试的真菌菌株.
- 高哺乳动物细胞活力 (~80%) 在2x MIC表示良好的生物相容性.
- AF3诱导了Candida albicans的显著超结构损伤,包括细胞形状和膜完整性的损失.
- 机制涉及膜透,脱极化,增加ROS产量,诱导细胞亡和DNA损伤.
结论:
- 脂AF3由于其破坏膜的活性和有利的生物相容性,显示出显著的抗真菌潜力.
- 由于AF3对蛋白质分解的稳定性及其多方面的作用机制,使其成为进一步开发抗真菌治疗药物的强有力的候选者.
相关概念视频
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


